Antitumor activity of 2‑[(2E)‑3,7‑dimethyl‑2,6‑octadienyl]‑6‑methyl‑2,5‑cyclohexadiene‑1,4‑dione isolated from the aerial part of Atractylodes macrocephala in hepatocellular carcinoma

Li,Lei; Zhao,Rui; Li,Ying; Wang,Wen‑Hui

doi:10.3892/mmr.2017.7385

Antitumor activity of 2‑[(2E)‑3,7‑dimethyl‑2,6‑octadienyl]‑6‑methyl‑2,5‑cyclohexadiene‑1,4‑dione isolated from the aerial part of Atractylodes macrocephala in hepatocellular carcinoma

Authors:
- Lei Li
- Rui Zhao
- Ying Li
- Wen‑Hui Wang
View Affiliations

Affiliations: Interventional Radiology Department, The First Hospital of Lanzhou University, Lanzhou, Gansu 730000, P.R. China, Liver Disease Department, The Second Hospital of Lanzhou University, Lanzhou, Gansu 730030, P.R. China, Liver Transplantation Center, The First Hospital of Lanzhou University, Lanzhou, Gansu 730000, P.R. China
Published online on: August 29, 2017 https://doi.org/10.3892/mmr.2017.7385
Pages: 6299-6305

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

2‑[(2E)‑3,7‑dimethyl‑2,6‑octadienyl]‑6‑methy l‑2,5‑cyclohexadiene‑1,4‑dione (DMD) is a compound isolated from Atractylodes macrocephala; however, its antitumor activity has not yet been investigated. Therefore, the present study aimed to investigate the antitumor activity of DMD in the H22 mouse hepatocellular carcinoma (HCC) cell line in vitro and in vivo. In the present study, the antiproliferative effects of DMD against H22 cells were evaluated using the MTT assay in vitro. Furthermore, xenograft nude mice were established to evaluate the antitumor effects of DMD on H22 cells in vivo. In addition, apoptosis of H22 cells was determined by flow cytometry with Annexin V‑fluorescein isothiocyanate/propidium iodide staining, and western blotting was subsequently performed to examine the expression levels of proteins associated with apoptosis, and c‑Jun N‑terminal kinase (JNK), p38 and extracellular signal‑regulated kinase (ERK)1/2 mitogen‑activated protein kinases (MAPKs). The results demonstrated that DMD exerts an antitumor effect against H22 cells in vitro and in vivo, and the underlying mechanism may be associated with mitochondria‑mediated apoptosis through upregulation of cytochrome c, cleaved (c)‑caspase‑3, c‑caspase‑9, c‑caspase‑7 and B‑cell lymphoma 2 (Bcl‑2)‑associated X protein, and downregulation of Bcl‑2. In addition, the antitumor effects of DMD against H22 cells may be also associated with the MAPK signaling pathway via increased p‑JNK and reduced p‑ERK1/2 expression. In conclusion, the present study demonstrated the DMD exerts antitumor effects against HCC in mice and provides a scientific basis for the clinical use of DMD for the treatment of HCC.

View Figures

View References

1	Xie QC and Yang YP: Anti-proliferative of physcion 8-O-β-glucopyranoside isolated from Rumex japonicas Houtt. on A549 cell lines via inducing apoptosis and cell cycle arrest. BMC Complem Altern Med. 14:3772014. View Article : Google Scholar
2	Li JP, Zhao DL, Jiang HJ, Huang YH, Li DQ, Wan Y, Liu XD and Wang JE: Assessment of tumor vascularization with functional computed tomography perfusion imaging in patients with cirrhotic liver disease. Hbpd Int. 10:43–49. 2011.PubMed/NCBI
3	Bruix J and Llovet JM: Prognostic assessment and evaluation of the benefits of treatment. J Clin Gastroenterol. 35 5 Suppl 2:S138–S142. 2002. View Article : Google Scholar : PubMed/NCBI
4	Marra M, Sordelli IM, Lombardi A, Lamberti M, Tarantino L, Giudice A, Stiuso P, Abbruzzese A, Sperlongano R, Accardo M, et al: Molecular targets and oxidative stress biomarkers in hepatocellular carcinoma: An overview. J Transl Med. 9:1712011. View Article : Google Scholar : PubMed/NCBI
5	Katsuta E, Tanaka S, Mogushi K, Matsumura S, Ban D, Ochiai T, Irie T, Kudo A, Nakamura N, Tanaka H, et al: Age-related clinicopathologic and molecular features of patients receiving curative hepatectomy for hepatocellular carcinoma. Am J Surg. 208:450–456. 2014. View Article : Google Scholar : PubMed/NCBI
6	Kasai K, Kuroda H and Suzuki K: Adjuvant therapy after treatment of hepatocellular carcinoma. Nippon Shokakibyo Gakkai Zasshi. 105:787–794. 2008.(In Japanese). PubMed/NCBI
7	Caraglia M, Giuberti G, Marra M, Addeo R, Montella L, Murolo M, Sperlongano P, Vincenzi B, Naviglio S, Prete SD, et al: Oxidative stress and ERK1/2 phosphorylation as predictors of outcome in hepatocellular carcinoma patients treated with sorafenib plus octreotide LAR. Cell Death Dis. 2:e1502011. View Article : Google Scholar : PubMed/NCBI
8	Fokunang CN, Ndikum V, Tabi OY, Jiofack RB, Ngameni B, Guedje NM, Tembe-Fokunang EA, Tomkins P, Barkwan S, Kechia F, et al: Traditional medicine: Past, present and future research and development prospects and integration in the national health system of Cameroon. Afr J Tradit Complement Altern Med. 8:284–295. 2011.PubMed/NCBI
9	Xie Q, Yang Y, Wang Z, Chen F, Zhang A and Liu C: Resveratrol-4-O-D-(2′-galloyl)-glucopyranoside isolated from Polygonum cuspidatum exhibits anti-hepatocellular carcinoma viability by inducing apoptosis via the JNK and ERK pathway. Molecules. 19:1592–1602. 2014. View Article : Google Scholar : PubMed/NCBI
10	Zhong YM and Feng YF: Advance on the chemical constituents and pharmacological effects of Atractylodes macrocephala Koidz. J Guangdong Coll Pharm. 1–221. 2012.
11	Peng W, Han T, Liu Q and Qin L: Chemical constituents from aerial part of Atractylodes macrocephala. Zhongguo Zhong Yao Za Zhi. 36:578–581. 2011.(In Chinese). PubMed/NCBI
12	National Institute of Health (NIH), . Public health service policy on humane care and use of laboratory animals. NIH; Bethesda, MD, USA: 2002
13	Resch M, Steigel A, Chen ZL and Bauer R: 5-Lipoxygenase and cyclooxygenase-1 inhibitory active compounds from Atractylodes lancea. J Nat Prod. 61:347–350. 1998. View Article : Google Scholar : PubMed/NCBI
14	Yang XK, Xu MY, Xu GS, Zhang YL and Xu ZX: In vitro and in vivo antitumor activity of scutebarbatine A on human lung carcinoma A549 cell lines. Molecules. 19:8740–8751. 2014. View Article : Google Scholar : PubMed/NCBI
15	Mattern J and Volm M: Imbalance of cell proliferation and apoptosis during progression of lung carcinomas. Anticancer Res. 24:4243–4246. 2004.PubMed/NCBI
16	Liu YL, Tang LH, Liang ZQ, You BG and Yang SL: Growth inhibitory and apoptosis inducing by effects of total flavonoids from Lysimachia clethroides Du by in human chronic myeloid leukemia K562 cells. J Ethnopharmacol. 131:1–9. 2010. View Article : Google Scholar : PubMed/NCBI
17	Okada H and Mak TW: Pathways of apoptotic and non-apoptotic death in tumor cells. Nat Rev Cancer. 4:592–603. 2004. View Article : Google Scholar : PubMed/NCBI
18	Chipuk JE, McStay GP, Bharti A, Kuwana T, Clarke CJ, Siskind LJ, Obeid LM and Green DR: Sphingolipid metabolism cooperates with Bak and Bax to promote the mitochondrial pathway of apoptosis. Cell. 148:988–1000. 2012. View Article : Google Scholar : PubMed/NCBI
19	Delivani P and Martin SJ: Mitochondrial membrane remodeling in apoptosis: An inside story. Cell Death Differ. 13:2007–2010. 2006. View Article : Google Scholar : PubMed/NCBI
20	Guerra-Castellano A, Díaz-Moreno I, Velázquez-Campoy A, De la Rosa MA and Díaz-Quintana A: Structural and functional characterization of phosphomimetic mutants of cytochrome c at threonine 28 and serine 47. Biochim Biophys Acta. 1857:387–395. 2016. View Article : Google Scholar : PubMed/NCBI
21	Zheng TS and Li X: Research progress in mitochondrial apoptosis pathway. Yixue Zongshu. 19:3282–3285. 2013.(In Chinese).
22	McIlwain DR, Berger T and Mak TW: Caspase functions in cell death and disease. Cold Spring Harb Perspect Biol. 5:a0086562013. View Article : Google Scholar : PubMed/NCBI
23	Xu J, Jiang S, Li Y, Li M, Cheng Q, Zhao D, Yang B, Jia Z, Wang L and Song L: Caspase-3 serves as an intracellular immune receptor specific for lipopolysaccharide in oyster Crassostrea gigas. Dev Comp Immunol. 61:1–12. 2016. View Article : Google Scholar : PubMed/NCBI
24	Gao N, Budhraja A, Cheng S, Yao H, Zhang Z and Shi X: Induction of apoptosis in human leukemia cells by grape seed extract occurs via activation of c-Jun NH2-terminal kinase. Clin Cancer Res. 15:140–149. 2009. View Article : Google Scholar : PubMed/NCBI
25	Chang L and Karin M: Mammalian MAP kinase signalling cascades. Nature. 410:37–40. 2001. View Article : Google Scholar : PubMed/NCBI
26	Pearson G, Robinson F, Gibson T Beers, Xu BE, Karandikar M, Berman K and Cobb MH: Mitogen-activated protein (MAP) kinase pathways: Regulation and physiological functions. Endocr Rev. 22:153–183. 2001. View Article : Google Scholar : PubMed/NCBI
27	Boutros T, Chevet E and Metrakos P: Mitogen-activated protein (MAP) Kinase/MAP kinase phosphatase regulation: Roles in cell growth, death, and cancer. Pharmacol Rev. 60:261–310. 2008. View Article : Google Scholar : PubMed/NCBI
28	Gao N, Budhraja A, Cheng S, Liu EH, Huang C, Chen J, Yang Z, Chen D, Zhang Z and Shi X: Interruption of the MEK/ERK signaling cascade promotes dihydroartemisinin-induced apoptosis in vitro and in vivo. Apoptosis. 16:511–523. 2011. View Article : Google Scholar : PubMed/NCBI